Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.
Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.
Eliminates prior authorization or step therapy requirement for prescriptions for any HIV prevention drug/prohibits the requirement of any copayment or the meeting of any deductible to obtain the prescription covered by the contract, plan, or policy.
Eliminates prior authorization or step therapy requirement for prescriptions for any HIV prevention drug/prohibits the requirement of any copayment or the meeting of any deductible to obtain the prescription covered by the contract, plan, or policy.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2025.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2025.
Includes the definition of "primary care services" and requires that all biennial reports shall include a review and recommendation of rates for primary care services on and after September 1, 2025.
Prohibits health benefit plans reviewing prescriptions for opioid addiction treatment.
Prohibits health benefit plans reviewing prescriptions for opioid addiction treatment.
Prohibits an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations.